Therapeutic Apheresis in Clinical Practice, ASFA,
Management of Osteoarthritis of the Knee, Hip and Hand, ACR,
Primary Osteoporosis and Low Bone Mass: 2026 Guideline Update, ACP,
Seasonal Respiratory Virus Vaccines in Immunocompromised Patients, IDSA,
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus, BSR (UKKA-endorsed),
Treatment of Adult and Juvenile Axial Spondyloarthritis, ACR/SAA/SPARTAN,
JAK Inhibitors for Inborn Errors of JAK–STAT Signalling, ESID/EBMT-IEWP/ERN-RITA,
International Collaboration for Better Kawasaki Disease Outcomes, AHA,
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV), NKF/KDOQI,
Physical Activity in Inflammatory Arthritis and Osteoarthritis, EULAR,
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, KDIGO,
Non-Biological and RNA-Based Therapies for Chronic Inflammatory Diseases, EAACI,
Corticosteroid Injections for Facet and Sacroiliac Joint Pain, ASRA Pain Medicine and partner societies,
Disease Activity Criteria for Adult-Onset Still’s Disease, EULAR,
Diagnosis and Treatment of Sacroiliac Joint Complex Pain, AAPM/ASRA Pain Medicine and partner societies,
Disease Activity Score for Antiphospholipid Syndrome, EULAR,
Prescribing and Monitoring Conventional DMARDs, BSR,
Treatment of Systemic Lupus Erythematosus, ACR,
Difficult-to-Manage and Treatment-Refractory Psoriatic Arthritis, EULAR,
Management of Lupus Nephritis, EULAR,
Management of Behçet’s Disease — 2025 Living Update, BAD/BSR,
Connective Tissue Disease-Associated Interstitial Lung Disease, ERS/EULAR,
Core Clinical Dataset for Systemic Lupus Erythematosus, EULAR,
Diagnosis and Management of VEXAS Syndrome, ACR,
Management of Psoriatic Arthritis, APLAR,
Management of ANCA-Associated Vasculitis, BSR,
Classification Criteria for Paediatric Chronic Nonbacterial Osteomyelitis, EULAR/ACR,
Risk of Progression from Arthralgia to Rheumatoid Arthritis, EULAR/ACR,
Screening, Treatment and Management of Lupus Nephritis, ACR,
Antirheumatic Drugs in Reproduction, Pregnancy and Lactation, EULAR,
Biologic and Targeted DMARDs for Axial Spondyloarthritis, BSR,
Foot Health in Inflammatory Arthritis, BSR,
Corticosteroid Injections in Joints and Musculoskeletal Soft Tissue, ASRA Pain Medicine and partner societies,
Difficult-to-Manage and Treatment-Refractory Axial Spondyloarthritis, ASAS,
Targeted Therapy in Inflammatory Arthritis After Cancer, EULAR,
Physical Activity and Pain Self-Management During Transitional Care, EULAR,
Management of Familial Mediterranean Fever, EULAR/PReS,
Treatment of Systemic Sclerosis, EULAR,
Imaging Referrals for Suspected or Known Axial Spondyloarthritis, ASAS,
Diagnosis and Management of Still’s Disease, EULAR/PReS,
Management of Systemic Sclerosis, BSR,
Management of Behçet’s Disease — 2024 Living Guideline, BAD/BSR,
Management of Adult and Juvenile-Onset Sjögren Disease, BSR,
Pharmacological Management of Psoriatic Arthritis, EULAR,
Imaging in Crystal-Induced Arthropathies, EULAR,
Nonpharmacological Management of Hip and Knee Osteoarthritis, EULAR,
